dr. HM (Hedwig) Blommestein

Erasmus School of Health Policy & Management

Associate professor | Health Technology Assessment (HTA)

Email: blommestein@eshpm.eur.nl

Pure profile

Work

Joyce Meijer, Nienke Hermanns, Rhodé Bijlsma, Hedwig M. Blommestein, Desiree H.J.G. van den Bongard, Thijs van Dalen, Paul J. van Diest, Caroline A. Drukker, Cristina Guerrero Paez, Aafke H. Honkoop, Agnes Jager, Linetta B. Koppert, Sabine C. Linn, Marissa C. van Maaren, Ester J. Siemerink, Laura J. van ’t, José H. Volders, Marie Jeanne Vrancken Peeters & Sabine Siesling (2026) - Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study - International Journal of Cancer - doi: 10.1002/ijc.70571 - [link]
R. van den Berg, G. D. Musters, C. Verhoef, H. M. Blommestein, P. J. Tanis, , S. Sharabiany, S. Kreisel, R. Hompes, J. B. Tuynman, O. Lapid, E. H.J. Belgers, B. Singh, A. A.W. van Geloven, R. J.C.L.M. Vuylsteke, J. H.W. de Wilt, J. Melenhorst, J. W.A. Leijtens, M. Vermaas, J. Rothbarth, J. W.A. Burger, F. Polat, H. F.J. Fabry, A. G.J. Aalbers, J. H. Wijsman, B. Lamme & A. van de Ven (2026) - Cost-effectiveness of the gluteal turnover flap for perineal wound closure after abdominoperineal resection: randomized clinical trial - BJS open, 10 (3) - doi: 10.1093/bjsopen/zrag059 - [link]
Diego Larrotta-Castillo, Yi Hsuan Chen, Luuk van der Hoek, Bram Ramaekers, Brenda Leeneman, Carin A. Uyl-De Groot, Johannes A. Langendijk & Hedwig M. Blommestein (2026) - Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer - Radiotherapy and Oncology, 219 - doi: 10.1016/j.radonc.2026.111473 - [link]
Noor Wortelboer, Seamus Kent, Hedwig M. Blommestein, Annemiek Van Ommen-Nijhof, Vincent Van der Noort, Esther Van den Pol, Cristina Guerrero Páez, Aart Beeker, Karin Beelen, Lisanne C. Hamming, Joan B. Heijns, Aafke H. Honkoop, Paul C. De Jong, Quirine C. Van Rossum-Schornagel, Christa Van Schaik-Van de Mheen, Jolien Tol, Cathrien S. Tromp-Van Driel, Suzan Vrijaldenhoven, A. Elise Van Leeuwen-Stok, Gabe S. Sonke, Agnes Jager & Inge R. Konings (2026) - Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial - Journal of the National Cancer Institute, 118 (3), 502-510 - doi: 10.1093/jnci/djaf334 - [link]
Brenda Leeneman, Hedwig M. Blommestein, Diana M.J. Delnoij & Maureen P.M.H. Rutten-Van Mölken (2026) - Evaluating international collaboration on horizon scanning for pharmaceuticals: Developing Key Performance Indicators for the International Horizon Scanning Initiative - International Journal of Technology Assessment in Health Care, 42 (1) - doi: 10.1017/S0266462325103358 - [link]
Lucas F. van Schaik, Brigitte Maes, Pieter Jan Volders, Guy Froyen, Philippe Aftimos, Evandro de Azambuja, Hedwig M. Blommestein, Wim H. van Harten & Valesca P. Retèl (2025) - Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population - JAMA network open, 8 (12) - doi: 10.1001/jamanetworkopen.2025.48538 - [link]
Noor Wortelboer, Seamus Kent, Inge R. Konings, Annemiek van Ommen-Nijhof, Vincent van der Noort, Esther van den Pol, Cristina Guerrero Páez, Marlies L. van Bekkum, Franchette W.P.J. van den Berkmortel, Helga J. Droogendijk, Danny Houtsma, Hendrika M. Oosterkamp, Annemieke van der Padt-Pruijsten, Ester J.M. Siemerink, Jolien Tol, Annette A. van Zweeden, A. Elise van Leeuwen-Stok, Gabe S. Sonke, Agnes Jager & Hedwig Blommestein (2025) - Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial - European Journal of Cancer, 231 - doi: 10.1016/j.ejca.2025.116051 - [link]
Maarten R. Seefat, Niek G. van der Maas, Kazem Nasserinejad, Bronno van der Holt, Anders Waage, Ulf Henrik Mellqvist, Annette Juul Vangsted, Anna J.T. Smit, Febe Smits, Paula F. Ypma, Niels W.C.J. van de Donk, Hedwig M. Blommestein, Jan J. Cornelissen, David G.J. Cucchi, Sonja Zweegman & Jurjen Versluis (2025) - Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial - EClinicalMedicine, 90 - doi: 10.1016/j.eclinm.2025.103605 - [link]
Diego A. Larrotta-Castillo, Hedwig M. Blommestein, Britt Kunnen, Joan J. Penninkhof, Agustinus J.A.J. van de Schoot, Mischa S. Hoogeman & Steven F. Petit (2025) - Cost-benefit analysis of advanced CBCT imaging: Incremental costs and savings - Radiotherapy and Oncology, 211 - doi: 10.1016/j.radonc.2025.111106 - [link]
Yi Hsuan Chen, Michiel Kroesen, Mischa S. Hoogeman, Matthijs M. Versteegh, Carin A. Uyl-de Groot & Hedwig M. Blommestein (2025) - Reply to comment on Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 54 - doi: 10.1016/j.ctro.2025.101013 - [link]